3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioma
7
Wilms Tumor
6
Rhabdoid Tumor
5
Osteosarcoma
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Neuroblastoma
5
Multiple Myeloma
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Leukemia, Myeloid, Acute
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Myelodysplastic Syndromes
4
Lymphoma
4
Lung Neoplasms
4
Central Nervous System Neoplasms
4
Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Colorectal Neoplasms
3
Burkitt Lymphoma
3
Sarcoma, Ewing
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neuroendocrine Tumors
2
Mycosis Fungoides
2
Melanoma
2
Malignant Solid Neoplasm
2
Interventions
pembrolizumab
9
Cetuximab
5
Surveys and Questionnaires
4
Cisplatin
4
dostarlimab
2
abemaciclib
2
Standard of Care
2
Docetaxel
2
Carboplatin
2
130-nm albumin-bound paclitaxel
2
ulixertinib
1
trastuzumab deruxtecan
1
toripalimab
1
tislelizumab
1
tipifarnib
1
ribociclib
1
repotrectinib
1
patritumab deruxtecan
1
palbociclib
1
olaparib
1
nimotuzumab
1
monalizumab
1
ibrutinib
1
fludarabine
1
exemestane
1
entrectinib
1
ebselen
1
durvalumab
1
disitamab vedotin
1
avelumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
X-Rays
×
30 days
×
Clear all
No trials found.